Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases.
$15.60+3.52%
报价 2026-11-09
市值
$992.1M
EV
$642.2M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -41.9%
$9.28$26.85
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-09不在筛选范围：industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| JBIOJade Biosciences, Inc. | $992.1M | +3.5% | – | 0% | – | – | – | |
| SLNSilence Therapeutics plc | $932.9M | +0.1% | – | 51% | – | – | – | |
| TECXTectonic Therapeutic, Inc. | $427.9M | +6.1% | – | 0% | – | – | – | |
| LYELLyell Immunopharma, Inc. | $377.9M | +3.8% | -100.0% | -8,537% | – | – | – | |
| CTNMContineum Therapeutics, Inc. Class A Common Stock | $364.1M | +8.2% | -28.3% | 0% | – | – | – | |
| KYTXKyverna Therapeutics, Inc. | $319.7M | +5.9% | +86.6% | 0% | – | – | – | |
| ACIUAC Immune S.A. | $248.3M | +9.4% | – | 100% | – | – | – | |
| GNLXGenelux Corporation | $93.7M | +5.6% | +32400.0% | -3,537.5% | – | – | – | |
| ALDXAldeyra Therapeutics, Inc. | $38.4M | +0.4% | +336.5% | 0% | – | – | – | |
| 同行中位数 | – | – | +86.6% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。